Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors (354 views)
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 2.857, 5-year impact factor: 2.97
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84876418788&partnerID=40&md5=aa2f278b7e903a87812cd3572a358f6b
Keywords: 111in-Octreotide, 18f-Fdg-Pet Ct, Functional Imaging, Multimodality Imaging, Thymic Epithelial Tumors, Thymic Neuroendocrine Tumors, Fluorodeoxyglucose F 18, Pentetreotide, Pentetreotide In 111, Adult, Article, Cancer Risk, Clinical Evaluation, Computer Assisted Emission Tomography, Controlled Study, Correlational Study, Drug Uptake, Epithelium Tumor, Female, Human, Primary Tumor, Statistical Significance, Thymic Epithelium Tumor, Thymoma, World Health Organization, Middle Aged, Neoplasms, Glandular And Epithelial, Positron-Emission Tomography And Computed Tomography, Retrospective Studies, Roc Curve, Thymus Neoplasms, Emission-Computed, Single-Photon,
Affiliations:
*** IBB - CNR ***
Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via Pansini 5 Edificio 10, 80131 Napoli, Italy
Institute of Biostructures and Bioimages, National Research Council, Italy
Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Italy
Rare Tumors Excellence Center, University Hospital Federico II, Naples, Italy
Department of Medicine and Surgery, University of Salerno, Salerno, Italy
References:
Srirajaskanthan, R., Toubanakis, C., Dusmet, M., A review of thymic tumors (2008) Lung Cancer, 60, pp. 4-1
Marom, E. M., Imaging thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S296-S303
Liu, R. S., Yeh, S. H., Huang, M. H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Sasaki, M., Kuwabara, Y., Ichiya, Y., Akashi, Y., Yoshida, T., Nakagawa, M., Murayama, S., Masuda, K., Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET (1999) Journal of Nuclear Medicine, 40 (10), pp. 1595-1601
Sung, Y. M., Lee, K. S., Kim, B. T., F-18-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups (2006) J Nucl Med, 47, pp. 1628-1634
Endo, M., Nakagawa, K., Ohde, Y., Utility of F-18DG-PET for differentiating the grade of malignancy in thymic epithelial tumors (2008) Lung Cancer, 61, pp. 350-355
Terzi, A., Bertolaccini, L., Rizzardi, G., Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms (2011) Lung Cancer, 74, pp. 239-243
Kaira, K., Endo, M., Abe, M., Biologic correlation of 2- [F-18] -fluoro- 2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors (2010) J Clin Oncol., 28, pp. 3746-3753
Nakajo, M., Kajiya, Y., Tani, A., F-18DG PET for grading malignancy in thymic epithelial tumors: Significant differences in F-18DG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study (2012) Eur J Radiol, 81, pp. 146-151
Masaoka, A., Staging system of thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S304-S312
Bombardieri, E., Ambrosini, V., Aktolun, K., 111In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1441-1448
Lastoria, S., Vergara, E., Palmieri, G., Acampa, W., Varrella, P., Caraco, C., Bianco, R. A., Salvatore, M., In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy (1998) Journal of Nuclear Medicine, 39 (4), pp. 634-639
Marienhagen, J., Schalke, B., Aebert, H., Held, P., Eilles, C., Bogdahn, U., Somatostatin receptor scintigraphy in thymoma imaging method and clinical application (1999) Pathology Research and Practice, 195 (8), pp. 575-581
Lin, K., Nguyen, Ba. D., Ettinger, D. S., Chin, B. B., Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma (1999) Clinical Nuclear Medicine, 24 (1), pp. 24-28. , DOI 10. 1097/00003072-199901000-00006
Miederer, M., Seidl, S., Buck, A., Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT (2009) Eur J Nucl Med Mol Imaging, 36, pp. 48-52
Carrasquillo, J. A., Chen, C. C., Molecular imaging of neuroendocrine tumors (2010) Semin Oncol, 37, pp. 662-679
Ferone, D., Pivonello, R., Van Martin Hagen, P., Dalm, V. A. S. H., Lichtenauer-Kaligis, E. G. R., Waaijers, M., Van Koetsveld, P. M., Hofland, L. J., Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes (2002) American Journal of Physiology - Endocrinology and Metabolism, 283 (5), pp. E1056-E1066
Palmieri, G., Lastoria, S., Colao, A., Vergara, E., Varrella, P., Biondi, E., Selleri, C., Salvatore, M., Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone (1997) New England Journal of Medicine, 336 (4), pp. 263-265. , DOI 10. 1056/NEJM199701233360405
Loehrer Sr., P. J., Wang, W., Johnson, D. H., Ettinger, D. S., Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial (2004) Journal of Clinical Oncology, 22 (2), pp. 293-299. , DOI 10. 1200/JCO. 2004. 02. 047
Kelly, R. J., Petrini, I., Rajan, A., Thymic malignancies: From clinical management to targeted therapies (2011) J Clin Oncol, 29, pp. 4820-4827
Marom, E.M., Imaging thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S296-S303
Liu, R.S., Yeh, S.H., Huang, M.H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Sung, Y.M., Lee, K.S., Kim, B.T., F-18-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups (2006) J Nucl Med, 47, pp. 1628-1634
Carrasquillo, J.A., Chen, C.C., Molecular imaging of neuroendocrine tumors (2010) Semin Oncol, 37, pp. 662-679
Loehrer Sr., P.J., Wang, W., Johnson, D.H., Ettinger, D.S., Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial (2004) Journal of Clinical Oncology, 22 (2), pp. 293-299. , DOI 10.1200/JCO.2004.02.047
Kelly, R.J., Petrini, I., Rajan, A., Thymic malignancies: From clinical management to targeted therapies (2011) J Clin Oncol, 29, pp. 4820-4827
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 2.857, 5-year impact factor: 2.97
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84876418788&partnerID=40&md5=aa2f278b7e903a87812cd3572a358f6b
Keywords: 111in-Octreotide, 18f-Fdg-Pet Ct, Functional Imaging, Multimodality Imaging, Thymic Epithelial Tumors, Thymic Neuroendocrine Tumors, Fluorodeoxyglucose F 18, Pentetreotide, Pentetreotide In 111, Adult, Article, Cancer Risk, Clinical Evaluation, Computer Assisted Emission Tomography, Controlled Study, Correlational Study, Drug Uptake, Epithelium Tumor, Female, Human, Primary Tumor, Statistical Significance, Thymic Epithelium Tumor, Thymoma, World Health Organization, Middle Aged, Neoplasms, Glandular And Epithelial, Positron-Emission Tomography And Computed Tomography, Retrospective Studies, Roc Curve, Thymus Neoplasms, Emission-Computed, Single-Photon,
Affiliations:
*** IBB - CNR ***
Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via Pansini 5 Edificio 10, 80131 Napoli, Italy
Institute of Biostructures and Bioimages, National Research Council, Italy
Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Italy
Rare Tumors Excellence Center, University Hospital Federico II, Naples, Italy
Department of Medicine and Surgery, University of Salerno, Salerno, Italy
References:
Srirajaskanthan, R., Toubanakis, C., Dusmet, M., A review of thymic tumors (2008) Lung Cancer, 60, pp. 4-1
Marom, E. M., Imaging thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S296-S303
Liu, R. S., Yeh, S. H., Huang, M. H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Sasaki, M., Kuwabara, Y., Ichiya, Y., Akashi, Y., Yoshida, T., Nakagawa, M., Murayama, S., Masuda, K., Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET (1999) Journal of Nuclear Medicine, 40 (10), pp. 1595-1601
Sung, Y. M., Lee, K. S., Kim, B. T., F-18-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups (2006) J Nucl Med, 47, pp. 1628-1634
Endo, M., Nakagawa, K., Ohde, Y., Utility of F-18DG-PET for differentiating the grade of malignancy in thymic epithelial tumors (2008) Lung Cancer, 61, pp. 350-355
Terzi, A., Bertolaccini, L., Rizzardi, G., Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms (2011) Lung Cancer, 74, pp. 239-243
Kaira, K., Endo, M., Abe, M., Biologic correlation of 2- [F-18] -fluoro- 2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors (2010) J Clin Oncol., 28, pp. 3746-3753
Nakajo, M., Kajiya, Y., Tani, A., F-18DG PET for grading malignancy in thymic epithelial tumors: Significant differences in F-18DG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study (2012) Eur J Radiol, 81, pp. 146-151
Masaoka, A., Staging system of thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S304-S312
Bombardieri, E., Ambrosini, V., Aktolun, K., 111In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1441-1448
Lastoria, S., Vergara, E., Palmieri, G., Acampa, W., Varrella, P., Caraco, C., Bianco, R. A., Salvatore, M., In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy (1998) Journal of Nuclear Medicine, 39 (4), pp. 634-639
Marienhagen, J., Schalke, B., Aebert, H., Held, P., Eilles, C., Bogdahn, U., Somatostatin receptor scintigraphy in thymoma imaging method and clinical application (1999) Pathology Research and Practice, 195 (8), pp. 575-581
Lin, K., Nguyen, Ba. D., Ettinger, D. S., Chin, B. B., Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma (1999) Clinical Nuclear Medicine, 24 (1), pp. 24-28. , DOI 10. 1097/00003072-199901000-00006
Miederer, M., Seidl, S., Buck, A., Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT (2009) Eur J Nucl Med Mol Imaging, 36, pp. 48-52
Carrasquillo, J. A., Chen, C. C., Molecular imaging of neuroendocrine tumors (2010) Semin Oncol, 37, pp. 662-679
Ferone, D., Pivonello, R., Van Martin Hagen, P., Dalm, V. A. S. H., Lichtenauer-Kaligis, E. G. R., Waaijers, M., Van Koetsveld, P. M., Hofland, L. J., Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes (2002) American Journal of Physiology - Endocrinology and Metabolism, 283 (5), pp. E1056-E1066
Palmieri, G., Lastoria, S., Colao, A., Vergara, E., Varrella, P., Biondi, E., Selleri, C., Salvatore, M., Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone (1997) New England Journal of Medicine, 336 (4), pp. 263-265. , DOI 10. 1056/NEJM199701233360405
Loehrer Sr., P. J., Wang, W., Johnson, D. H., Ettinger, D. S., Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial (2004) Journal of Clinical Oncology, 22 (2), pp. 293-299. , DOI 10. 1200/JCO. 2004. 02. 047
Kelly, R. J., Petrini, I., Rajan, A., Thymic malignancies: From clinical management to targeted therapies (2011) J Clin Oncol, 29, pp. 4820-4827
Marom, E.M., Imaging thymoma (2010) J Thorac Oncol, 5 (SUPPL. 4), pp. S296-S303
Liu, R.S., Yeh, S.H., Huang, M.H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Sung, Y.M., Lee, K.S., Kim, B.T., F-18-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups (2006) J Nucl Med, 47, pp. 1628-1634
Carrasquillo, J.A., Chen, C.C., Molecular imaging of neuroendocrine tumors (2010) Semin Oncol, 37, pp. 662-679
Loehrer Sr., P.J., Wang, W., Johnson, D.H., Ettinger, D.S., Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial (2004) Journal of Clinical Oncology, 22 (2), pp. 293-299. , DOI 10.1200/JCO.2004.02.047
Kelly, R.J., Petrini, I., Rajan, A., Thymic malignancies: From clinical management to targeted therapies (2011) J Clin Oncol, 29, pp. 4820-4827
Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors
PURPOSE: This study aimed to test the role of combined imaging with F-FDG-PET/CT and In-octreotide SPECT in characterizing thymic epithelial tumors (TETs). METHODS: We evaluated 20 patients with newly diagnosed TETs who had undergone concomitant F-FDG-PET/CT and In-octreotide SPECT. Thymic epithelial tumors were classified by World Health Organization (WHO) as low-risk thymomas (5), high-risk thymomas (4), and thymic carcinomas (11, among which 6 neuroendocrine tumors). Patients were staged according to Masaoka system. F-FDG-PET/CT was performed and SUVmax of primary tumors was recorded. In-octreotide SPECT of the thorax was performed, and tumor-to-background ratio was determined on the 24-hour coronal sections. RESULTS: All patients showed increased F-FDG uptake in mediastinal lesions. SUVmax were significantly correlated with WHO classification (r = 0. 66, P < 0. 01) and with Masaoka stage (r = 0. 60, P < 0. 01). SUVmax of low-risk thymomas (mean [SD], 2. 87 [0. 83]) were significantly lower than those of high-risk thymomas (mean [SD], 7. 21 [1. 73], P < 0. 01) and of thymic carcinomas (mean [SD], 9. 39 [5. 80], P < 0. 05), whereas no significant difference was found between high-risk thymomas and thymic carcinomas. SUVmax of all high-risk thymomas and thymic carcinomas was 4. 5 or greater. All primary tumors were detected by In-octreotide SPECT, and tumor-to-background ratios ranged between 1. 67 and 10. 10. No statistically significant correlation was found between tumor-to-background ratios and WHO classification (r = 0. 24, P = 0. 36) and Masaoka stages (r = 0. 31, P = 0. 23). However tumor-to-background ratios of thymic neuroendocrine tumors (mean [SD], 5. 71 [3. 09]) were significantly higher than those of all other TETs with SUVmax of 4. 5 or greater (mean [SD], 2. 41 [0. 56]; P < 0. 05). CONCLUSIONS: F-FDG-PET/CT scan allows to differentiate high-risk epithelial tumors and thymic carcinomas from low-risk thymomas, whereas In-octreotide SPECT may identify neuroendocrine tumors among those showing high F-FDG uptake. 2013 by Lippincott Williams & Wilkins
PURPOSE: This study aimed to test the role of combined imaging with F-FDG-PET/CT and In-octreotide SPECT in characterizing thymic epithelial tumors (TETs). METHODS: We evaluated 20 patients with newly diagnosed TETs who had undergone concomitant F-FDG-PET/CT and In-octreotide SPECT. Thymic epithelial tumors were classified by World Health Organization (WHO) as low-risk thymomas (5), high-risk thymomas (4), and thymic carcinomas (11, among which 6 neuroendocrine tumors). Patients were staged according to Masaoka system. F-FDG-PET/CT was performed and SUVmax of primary tumors was recorded. In-octreotide SPECT of the thorax was performed, and tumor-to-background ratio was determined on the 24-hour coronal sections. RESULTS: All patients showed increased F-FDG uptake in mediastinal lesions. SUVmax were significantly correlated with WHO classification (r = 0. 66, P < 0. 01) and with Masaoka stage (r = 0. 60, P < 0. 01). SUVmax of low-risk thymomas (mean [SD], 2. 87 [0. 83]) were significantly lower than those of high-risk thymomas (mean [SD], 7. 21 [1. 73], P < 0. 01) and of thymic carcinomas (mean [SD], 9. 39 [5. 80], P < 0. 05), whereas no significant difference was found between high-risk thymomas and thymic carcinomas. SUVmax of all high-risk thymomas and thymic carcinomas was 4. 5 or greater. All primary tumors were detected by In-octreotide SPECT, and tumor-to-background ratios ranged between 1. 67 and 10. 10. No statistically significant correlation was found between tumor-to-background ratios and WHO classification (r = 0. 24, P = 0. 36) and Masaoka stages (r = 0. 31, P = 0. 23). However tumor-to-background ratios of thymic neuroendocrine tumors (mean [SD], 5. 71 [3. 09]) were significantly higher than those of all other TETs with SUVmax of 4. 5 or greater (mean [SD], 2. 41 [0. 56]; P < 0. 05). CONCLUSIONS: F-FDG-PET/CT scan allows to differentiate high-risk epithelial tumors and thymic carcinomas from low-risk thymomas, whereas In-octreotide SPECT may identify neuroendocrine tumors among those showing high F-FDG uptake. 2013 by Lippincott Williams & Wilkins
Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors
| ▼ Evaluation of gene expression and test of new therapies by preclinical imaging in murine models |
| ▼ Phenotyping of murine models by preclinical imaging |
| ▼ Clinical Oncology |
Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors
Other filter: ([btitle,keywords] "111in-Octreotide" OR ...
D'Andrea A, Radmilovic J, Carbone A, Forni A, Tagliamonte E, Riegler L, Liccardo B, Crescibene F, Sirignano C, Esposito G, Bossone E
* Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis (78 views) (PDF 11 views)
World Journal Of Radiology, 2020 May; 21(5): 345-353.
Impact Factor: 0.57
View Export to BibTeX Export to EndNote
Perillo T, Romeo V, Amitrano M, Cuocolo R, Stanzione A, Sirignano C, Soscia E, Maurea S
* Atypical dermoid cyst of the ovary during pregnancy: A multi-modality diagnostic approach (66 views) (PDF 11 views)
Radiol Case Rep (ISSN: 1930-0433linking, 1930-0433electronic), 2020 Jan 15; 15(3): 298-301.
Impact Factor: 0.59
View Export to BibTeX Export to EndNote
Cocchia R, D'Andrea A, Conte M, Cavallaro M, Riegler L, Citro R, Sirignano C, Imbriaco M, Cappelli M, Gregorio G, Calabro R, Bossone E
* Patient selection for transcatheter aortic valve replacement: A combined clinical and multimodality imaging approach (206 views) (PDF 6 views)
World J Cardiol (ISSN: 1949-8462print), 2017 Mar 26; 9(3): 212-229.
Impact Factor: 2.55
View Export to BibTeX Export to EndNote
Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (256 views)
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 3.016
View Export to BibTeX Export to EndNote
Giorgio SM, Caprio MG, Galante F, Russo G, Romano A, Vergara E, Alessio M, Cuocolo A
* Clinical Value of Perfusion Abnormalities of Brain on Technetium-99m HMPAO Single-Photon Emission Computed Tomography in Children With Sydenham Chorea (284 views) (PDF 150 views)
J Child Neurol (ISSN: 0883-0738), 2016 Dec 05; 32(3): 316-321.
Impact Factor: 1.378
View Export to BibTeX Export to EndNote
De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (334 views)
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
View Export to BibTeX Export to EndNote
Consolino L, Longo DL, Dastrù W, Cutrin JC, Dettori D, Lanzardo S, Oliviero S, Cavallo F, Aime S
* Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging (308 views)
Int J Cancer (ISSN: 0020-7136), 2016; N/D: N/D-N/D.
Impact Factor: 6.513
View Export to BibTeX Export to EndNote
Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (270 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
* Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (587 views)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.
Impact Factor: 5.774
View Export to BibTeX Export to EndNote
Palmieri G, Fonti R, Federico P, Del Prete G, Pacelli R, Pace L, Salvatore M, Del Vecchio S
* Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors (272 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
View Export to BibTeX Export to EndNote
Cuocolo A, Breatnach E
* Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) (460 views)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2010 Jan; 37(1): 163-167.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B
* Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease (360 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.
Impact Factor: 1.888
View Export to BibTeX Export to EndNote
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
* F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma (549 views)
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.
Impact Factor: 6.662
View Export to BibTeX Export to EndNote
Cuocolo A
The Rapid Growth Of Multimodality Imaging In Europe Multimodality (mm) Imaging: Enhancement Through Interlacing (214 views)
European Journal Of Nuclear Medicine And Molecular Imaging, 2008; 35: 1221-1229.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Adam A, Cuocolo A
The "White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging": a message from the ESR and EANM Presidents (339 views)
Eur Radiol (ISSN: 0938-7994, 1432-1084electronic, 0938-7994linking), 2007 Sep; 17(8): 1924-1925.
Impact Factor: 3.405
View Export to BibTeX Export to EndNote
Bischof Delaloye A, Carrio I, Cuocolo A, Knapp W, Gourtsoyiannis N, Mccall I, Reiser M, Silberman B
* White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging (363 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Sep; 34(8): 1147-1151.
Impact Factor: 4.101
View Export to BibTeX Export to EndNote
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
* Multimodality Imaging With 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Of Multiple Myeloma (321 views)
Proceedings Of The 2nd International Conference Of The European Society For Molecular Imaging Naples Italy, 2007; N/D: 56-56.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (409 views)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
View Export to BibTeX Export to EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (462 views)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
View Export to BibTeX Export to EndNote
Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma (354 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
View Export to BibTeX Export to EndNote
Brunetti A, Alfano B, Soricelli A, Tedeschi E, Mainolfi C, Covelli EM, Aloj L, Panico M, Bazzicalupo L, Salvatore M
Functional characterization of brain tumors: An overview of the potential clinical value (835 views) (PDF 245 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 699-715.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Brunetti A, Soricelli A, Rotondo A, Alfano B, Raman R, Celentano L, Di Chiro G, Salvatore M
Correlative morphologic and functional imaging for diagnosis, staging and follow up in AIDS: an overview (244 views)
Q J Nucl Med (ISSN: 1125-0135, 0392-2020, 1124-3937), 1995 Sep; 39(3): 201-211.
Impact Factor: 2.125
View Export to BibTeX Export to EndNote
* Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis (78 views) (PDF 11 views)
World Journal Of Radiology, 2020 May; 21(5): 345-353.
Impact Factor: 0.57
View Export to BibTeX Export to EndNote
Perillo T, Romeo V, Amitrano M, Cuocolo R, Stanzione A, Sirignano C, Soscia E, Maurea S
* Atypical dermoid cyst of the ovary during pregnancy: A multi-modality diagnostic approach (66 views) (PDF 11 views)
Radiol Case Rep (ISSN: 1930-0433linking, 1930-0433electronic), 2020 Jan 15; 15(3): 298-301.
Impact Factor: 0.59
View Export to BibTeX Export to EndNote
Cocchia R, D'Andrea A, Conte M, Cavallaro M, Riegler L, Citro R, Sirignano C, Imbriaco M, Cappelli M, Gregorio G, Calabro R, Bossone E
* Patient selection for transcatheter aortic valve replacement: A combined clinical and multimodality imaging approach (206 views) (PDF 6 views)
World J Cardiol (ISSN: 1949-8462print), 2017 Mar 26; 9(3): 212-229.
Impact Factor: 2.55
View Export to BibTeX Export to EndNote
Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (256 views)
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 3.016
View Export to BibTeX Export to EndNote
Giorgio SM, Caprio MG, Galante F, Russo G, Romano A, Vergara E, Alessio M, Cuocolo A
* Clinical Value of Perfusion Abnormalities of Brain on Technetium-99m HMPAO Single-Photon Emission Computed Tomography in Children With Sydenham Chorea (284 views) (PDF 150 views)
J Child Neurol (ISSN: 0883-0738), 2016 Dec 05; 32(3): 316-321.
Impact Factor: 1.378
View Export to BibTeX Export to EndNote
De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (334 views)
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
View Export to BibTeX Export to EndNote
Consolino L, Longo DL, Dastrù W, Cutrin JC, Dettori D, Lanzardo S, Oliviero S, Cavallo F, Aime S
* Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging (308 views)
Int J Cancer (ISSN: 0020-7136), 2016; N/D: N/D-N/D.
Impact Factor: 6.513
View Export to BibTeX Export to EndNote
Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (270 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
* Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (587 views)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.
Impact Factor: 5.774
View Export to BibTeX Export to EndNote
Palmieri G, Fonti R, Federico P, Del Prete G, Pacelli R, Pace L, Salvatore M, Del Vecchio S
* Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors (272 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
View Export to BibTeX Export to EndNote
Cuocolo A, Breatnach E
* Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) (460 views)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2010 Jan; 37(1): 163-167.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B
* Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease (360 views)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.
Impact Factor: 1.888
View Export to BibTeX Export to EndNote
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
* F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma (549 views)
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.
Impact Factor: 6.662
View Export to BibTeX Export to EndNote
Cuocolo A
The Rapid Growth Of Multimodality Imaging In Europe Multimodality (mm) Imaging: Enhancement Through Interlacing (214 views)
European Journal Of Nuclear Medicine And Molecular Imaging, 2008; 35: 1221-1229.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Adam A, Cuocolo A
The "White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging": a message from the ESR and EANM Presidents (339 views)
Eur Radiol (ISSN: 0938-7994, 1432-1084electronic, 0938-7994linking), 2007 Sep; 17(8): 1924-1925.
Impact Factor: 3.405
View Export to BibTeX Export to EndNote
Bischof Delaloye A, Carrio I, Cuocolo A, Knapp W, Gourtsoyiannis N, Mccall I, Reiser M, Silberman B
* White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging (363 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Sep; 34(8): 1147-1151.
Impact Factor: 4.101
View Export to BibTeX Export to EndNote
Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M
* Multimodality Imaging With 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Of Multiple Myeloma (321 views)
Proceedings Of The 2nd International Conference Of The European Society For Molecular Imaging Naples Italy, 2007; N/D: 56-56.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (409 views)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
View Export to BibTeX Export to EndNote
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (462 views)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
View Export to BibTeX Export to EndNote
Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma (354 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
View Export to BibTeX Export to EndNote
Brunetti A, Alfano B, Soricelli A, Tedeschi E, Mainolfi C, Covelli EM, Aloj L, Panico M, Bazzicalupo L, Salvatore M
Functional characterization of brain tumors: An overview of the potential clinical value (835 views) (PDF 245 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 699-715.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Brunetti A, Soricelli A, Rotondo A, Alfano B, Raman R, Celentano L, Di Chiro G, Salvatore M
Correlative morphologic and functional imaging for diagnosis, staging and follow up in AIDS: an overview (244 views)
Q J Nucl Med (ISSN: 1125-0135, 0392-2020, 1124-3937), 1995 Sep; 39(3): 201-211.
Impact Factor: 2.125
View Export to BibTeX Export to EndNote
22 Records (17 excluding Abstracts).
Total impact factor: 66.237 (46.893 excluding Abstracts).
Total 5 year impact factor: 63.559 (43.625 excluding Abstracts).
Total impact factor: 66.237 (46.893 excluding Abstracts).
Total 5 year impact factor: 63.559 (43.625 excluding Abstracts).
354 views. Last view on Friday 19 May 2023, 2:17:42
ibb.cnr.it
